InfuSystem Holdings (INFU) Return on Capital Employed Growth (1y) (2012 - 2026)
InfuSystem Holdings (INFU) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | -81.00 |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | -1,390.00 |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 39.00 |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | -110.00 |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | -3,185.00 |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 658.00 |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | 125.00 |
| 10 | InfuSystem Holdings | 189.28 Mn | 187.17 Mn | 19.68 Mn | 614.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 614.00 |
| Dec 31, 2025 | 705.00 |
| Sep 30, 2025 | 720.00 |
| Jun 30, 2025 | 749.00 |
| Mar 31, 2025 | 563.00 |
| Dec 31, 2024 | 323.00 |
| Sep 30, 2024 | 175.00 |
| Jun 30, 2024 | 88.00 |
| Mar 31, 2024 | 149.00 |
| Dec 31, 2023 | 276.00 |
| Sep 30, 2023 | 180.00 |
| Jun 30, 2023 | 236.00 |
| Mar 31, 2023 | 69.00 |
| Dec 31, 2022 | -143.00 |
| Sep 30, 2022 | -20.00 |
| Jun 30, 2022 | -645.00 |
| Mar 31, 2022 | -1,015.00 |
| Dec 31, 2021 | -1,006.00 |
| Sep 30, 2021 | -1,180.00 |
| Jun 30, 2021 | -432.00 |